Other Clinical Trial - Bellomic PCA in Laparoscopic Gynecologic Surgery

Clinical Trial Summary

In laparoscopic gynecological surgery, when intravenous patient-controlled analgesia (IV-PCA) device is used after surgery, the degree of postoperative side effects and pain control is compared when a combination of fentanyl and ketorolac is administered compared to when fentanyl alone is used.

See also
Status	Clinical Trial	Phase
Terminated	`NCT04799210` - Human Factors Actual-Use Clinical Protocol	N/A
Not yet recruiting	`NCT03845608` - Analgesic Effect of Pulmonary Recruitment and Intraperitoneal Hydrocortisone in Laparoscopic Gynecological Surgery	Phase 4
Recruiting	`NCT05936671` - EEG and ANI Guided Anesthesia and Quality of Recovery	N/A
Withdrawn	`NCT01955798` - Direct Trocar Entry Versus Veress Needle Entry in Laparoscopic Gynecological Surgery	N/A

See also

Status

Clinical Trial

Phase

Terminated

NCT04799210 - Human Factors Actual-Use Clinical Protocol

N/A

Not yet recruiting

NCT03845608 - Analgesic Effect of Pulmonary Recruitment and Intraperitoneal Hydrocortisone in Laparoscopic Gynecological Surgery

Phase 4

Recruiting

NCT05936671 - EEG and ANI Guided Anesthesia and Quality of Recovery

N/A

Withdrawn

NCT01955798 - Direct Trocar Entry Versus Veress Needle Entry in Laparoscopic Gynecological Surgery

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05489796
Study type	Interventional
Source	Seoul National University Bundang Hospital
Contact
Status	Completed
Phase	N/A
Start date	June 30, 2022
Completion date	August 31, 2022

Bellomic PCA in Laparoscopic Gynecologic Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms